The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research ...

The most talked about and market moving research calls around Wall Street are now in one place. Here are today’s research calls that investors need to know, as compiled by The Fly. Top Upgrades ...

CVS Health reports Q4 earnings on Feb. 12, with analysts watching cost trends, Medicare Advantage enrollment, and medical loss ratio impacts.

To make our list of the stocks that Jim Cramer talked about, we listed down the stocks he mentioned during CNBC’s Squawk on ...

Founder of All Source Investment Management, explains tax strategies and private equity sources for wealth development ...

Elon Musk’s Department of Government Efficiency team has been working at the Centers for Medicare and Medicaid Services, where they have gotten ...

CVS has replaced its CEO, and is working to reassure investors. The stock has jumped more than 20% in the first weeks of 2025 ...

After decades of research, Vertex Pharmaceuticals now has an approved pain medication. Can one of the world’s most powerful ...

In this article, we are going to take a look at where The Cigna Group (NYSE ... on CNBC’s Squawk on the Street, Jim Cramer commented on the potential impact on Wall Street from President Trump ...

Let's sort the S&P 500 healthcare sector again to show the 10 stocks with the highest percentages of "buy" or equivalent ratings. Only five companies are on both this list and the above growth list: ...